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HyperlipidemiaAbstract Many traditional plants have been used to fight life-threatening diseases such as diabetes.
These plants have been shown to possess antioxidant activities, improving the diabetes inconve-
niences. Wister albino rats became diabetic by streptozotocin (STZ) induction. The effect of
200 mg/kg ethanolic extracts of either Cinnamomum zeylanicum bark (CZ) or Syzygium cumini seeds
(SC) was investigated on STZ-induced diabetic rats. The impact of CZ or SC administration was
observed. Blood glucose, insulin level, hemoglobin content, lipid profile, liver and kidney functions,
and antioxidant enzymes in plasma were evaluated. Diabetic rats exhibited an increase in the
levels of blood glucose, total cholesterol, triglycerides and low density lipoprotein cholesterol
(LDL-cholesterol). In contrast, the levels of insulin and high density lipoprotein cholesterol
(HDL-cholesterol) were diminished.
The oral administration of CZ and SC showed a decrease in glucose level, total cholesterol,
triglycerides, and LDL-cholesterol, whereas an increase in insulin level and HDL-cholesterol were
recorded. What’s more, the antioxidant enzymes in diabetic control rats showed significantly abnor-
mal activities of low superoxide dismutase (SOD), catalase (CAT), glutathione peroxide (GPx)
activities and reduced glutathione (GSH) compared to treated diabetic rats. Also, in the extent
of lipid peroxidation (LPO).
Both CZ and SC possessed antioxidant activity as shown by elevated SOD and GPx activities and
reduction in LPO. CZ and SC are functioning to improve the level of insulin, hyperglycemia, hyper-
lipidemia, oxidative stress and kidney and liver dysfunctions in STZ-induced diabetic rats.
 2015 The Egyptian German Society for Zoology. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The metabolic disorders such as hyperglycemia, altered lipid
profile, carbohydrates and protein metabolisms and increased
risk of cardiovascular disease complications are associated
with diabetes mellitus (Davis and Granner, 2001). It is influ-
encing upwards of around 200 million throughout the world.
Both types 1 and 2 of diabetes offer hyperglycemia, microvas-
cular and macrovascular intricacies. Moreover, the altered
lipoprotein metabolism has been involved in both forms of dia-
betes in the pathogenesis of the cardiovascular ailment
(Howard, 1987). Furthermore, expanded free radicals’ level
is accompanied with diabetes which has been seen as debili-
tated antioxidant defense. Progression of diabetes and its com-
plications are caused by oxidative anxiety (Berryman et al.,
2004). Currently, medications such as oral hypoglycemic
agents and insulin control diabetes sickness have their own
constrains. It has been found that the antioxidant action of
many traditional medicinal plants may play some role in their
remedial activities (Tanko et al., 2008). Cinnamomum zeylan-
icum (CZ) and Syzygium cumini (SC) are used in the present
study as ethanolic extracts. Previous studies specify the active
ingredients of both plant extracts. The primary constituents of
CZ bark oil are trans cinnamaldehyde (72.0–82.15%), which is
assessed by GC–MS analysis (Wang et al., 2009). Minor con-
stituents were estimated in all Cinnamomum species such as
trans cinnamyl acetate (3.24–3.65%), eugenol (1.07–13.3%),
trans cinnamyl alcohol (0.5–0.6%), o-methoxy benzaldehyde
(0.09–0.15%), benzyl benzoate (0.4–1.0%), a-terpineol (0.35–
0.62%), b-caryophyllene (1.0–2.0%), linalool (0.7–1.06%),
limonene (0.09–0.095%), myrcene (0.07–0.08%), b-pinene
(0.02–0.03%), traces of benzaldehyde and trans cinnamic acid
have been estimated by GC (Charalambous, 1994; Wang et al.,
2011; Kamaliroosta et al., 2012). Gas chromatography of
ethanolic extract of SC seeds reveals the presence of gallic acid,
ellagic acid, corilagin and related ellagitannins, 3,6-hexahy
droxydiphenoyl-glucose and its isomer, 4,6-hexahydroxydip
henoyl glucose, 1-galloyl glucose, 3-galloyl glucose and
quercetin (Bhatia and Bajaj, 1975). The seed oil consists of
33.2% 1-chlorooctadecane, 9.24% tetratetracontane, 8.02%
decahydro-8a-ethyl-1,1,4a,6-tetramethylnapahthalene, 5.29%
4-(2-2-dimethyl-6-6-methylenecyclohexyl) butanol, 5.15% octade-
cane, 3.97% octacosane, 1.72% heptacosane and 1.71% eicosane
(Kumar et al., 2009).
The present study explores the possible action of medicinal
plants, C. zeylanicum and S. cumini that may treat oxidative
anxiety in experimental diabetic rats. Additionally to deter-
mine whether the ethanolic extracts of CZ and SC have any
lipidemic impact or anti-progression of diabetic complications.
Materials and methods
Plant
CZ bark and SC seed samples were collected from the market
in Riyadh. Identification of samples was done on record in the
herbarium of the research center for Medicinal Aromatic and
Poisonous Plants, College of Pharmacy, King Saud University,
Riyadh, SA.Extraction of CZ bark and SC seeds
CZ Barks and SC seeds were both washed separately under
running tap water followed by sterile distilled water. These
were dried at room temperature (300C) for 2 days and ground
to fine powder then stored in air-tight bottles. Ethanolic
extraction was done by dissolving 10 g of bark or seed powder
in 100 ml ethanol with shaking then kept for 24 h. The suspen-
sion was filtered then extract was concentrated under vacuum
below 400C using Rotary Evaporator System (Cole-Parmer).
UV rays for 24 h were applied on the dried extract that was
checked for sterility on nutrient agar plates. The extract was
stored in a freezer at 40C, in labeled sterile bottles until use.
Animal
Thirty healthy adult male Wister albino rats weighing
150–200 g, 2–3 months of age were used for the present study.
Animals were caged individually under controlled standard
conditions of light, temperature and humidity. They were fed
with standard pellet diet and provided water ad libitum. All
experiments were conducted according to the ethical guidelines
of the International Association for the Study of Pain
(Zimmermann, 1983) and the standard guidelines for animal
use.
Experiment
Twenty-four animals were grouped into four trials as follows:
(1) Normal Control rats (6 rats) administered citrate buffer
(0.1, pH 4.5; i.p).
(2) Diabetic Control rats (6 rats) which were
Streptozotocin-induced diabetic rats.
(3) S. cumini (6 rats). STZ-induced diabetic rats were
administered 200 mg SC/kg body weight 14 days after
induction of diabetes. Oral administration of SC was
given for 4 weeks, once weekly.
(4) C. zeylanicum (6 rats). STZ-induced diabetic rats were
administered 200 mg CZ/kg body weight 14 days after
induction of diabetes. Oral administration of CZ was
given for 4 weeks, once weekly.
Diabetes mellitus induction
In the overnight fasted rats, streptozotocin (STZ) (Sigma
Chemicals, St. Louis, MO, USA) dissolved in freshly prepared
0.1 M cold citrate buffer, pH 4.5 was injected intraperitoneally
(60 mg/kg) (Ramachandran et al., 2011). To avoid fatal hypo-
glycemia after 6 h of STZ injection, rats received 5% dextrose
solution for the next 24 h (Tanko et al., 2008). Blood glucose
levels were measured to confirm diabetes after 72 h by using
one touch glucometer with glucose oxidase–peroxidase strips.
Diabetic rats were kept 14 days under standard laboratory
condition for stabilizing blood glucose levels. After 14 days
of diabetes induction, blood glucose levels were rechecked.
Animals with blood glucose level higher than 250 mg/dl were
picked out for the current experiments.
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Rats were anaesthetized with halothane (4%) to collect blood
from the cardiac puncture. Also, livers were taken for monitor-
ing antioxidant activity. Glucose was determined directly after
collecting blood. The rest of blood was kept frozen as a serum
at 20 C.
Glucose, insulin and hemoglobin estimation
Glucose was determined according to the method of Trinder
(1969). Serum insulin was determined by radioimmunoassay
method using rat insulin as a standard, according to
Adebajo et al. (2007). The hemoglobin (Hb) and glycosylated
hemoglobin (HbA1c) were estimated in fresh blood using the
cyanomethemoglobin method described by van and Zijlstra
(1961).
Kidney & liver functions
The serum creatinine, urea, total protein, serum glutamate-
pyruvate transaminase (SGPT) and serum glutamate–oxaloac-
etate transaminase (SGOT) levels were analyzed by commercial
kits (Span Diagnostics Ltd, Surat, India). All biochemical
parameters were estimated using semi-autoanalyzer (Photome-
ter, Germany).
Serum lipid profiles
Cholesterol and triglycerides were determined according to
Richmond (1973) and Young (1997). Low-density lipoproteins
(LDL) and very low density lipoproteins (VLDL) in samples
precipitate with phosphotungestate and magnesium ions
(Young, 1995). After centrifugation, the cholesterol concentra-
tion in the HDL fraction remaining in the supernatant is deter-
mined (Lopes-Virella et al., 1977).
Liver antioxidants
Lipid peroxidation (LPO) was assayed according to the method
of Ohkawa et al. (1979). Superoxide dismutase (SOD) activity
was assayed according to the method of Marklund and
Marklund (1974). Catalase activity was measured based on
the ability of the enzyme to break down H2O2 (Sinha, 1972).Table 1 Hypoglycemic activity of Cinnamomum zeylanicum (C
(mean ± SE) (n= 6).
Treatment Blood glucose (mg/dL)
14 days of STZ injection 1 week
Normal control 71.3 ± 4.6 74.9 ± 5.1
Diabetic control 280.4 ± 16.2a 261.5 ± 16.2a
SC treatment 268.8 ± 13.1b 168.6 ± 14.1*
CZ treatment 257.5 ± 21.2 176.2 ± 12.3c*
a p< 0.001 between the normal control and diabetic control.
b p< 0.001 between the diabetic control and SC treatment.
c p< 0.05 between the diabetic control and CZ treatment.
* p< 0.01 between STZ injection and SC or CZ treatment.Non-enzymatic antioxidant as reduced glutathione (GSH)
was determined by the method of Ellman (1959).
Statistical analysis
Results are expressed as mean ± SE. Statistical analysis was
performed on SPSS software (version 18) using unpaired Stu-
dent’s t-test, to compare results between two groups at differ-
ent times. Moreover, comparison within each group (before-
after test) was conducted using ANOVA and Bonferroni’s
Multiple Comparison Test. P values less than 0.05 were con-
sidered statistically significant.
Results
Effect of ethanolic extract of CZ and SC on blood glucose level
The blood glucose levels were significantly increased after the
injection of STZ compared to the normal control rats (Table 1).
There was a significant decrease in blood glucose level after
treatment of 200 mg/kg SC (p< 0.05) or CZ however the drop
was more significant (p< 0.001) (Table 1).
Effect of ethanolic extract of CZ and SC on serum insulin levels
STZ-induced rats of diabetes had decreased level of serum
insulin significantly (p< 0.001) in comparison with normal
control rats, while the treatment of SC and CZ significantly
(p< 0.001 and p< 0.05) increased serum insulin levels,
toward normal levels, more than diabetic control rats (Table 2).
Effect of ethanolic extract of CZ and SC on Hb, HbA1c
Induction of diabetes significantly (p< 0.001) increased the
level of HbA1c, but decreased the level of Hb when compared
to normal control rats (Table 2). In diabetic rats, treatment of
SC and CZ significantly (p< 0.001 and p< 0.05) reduced ele-
vated HbA1c levels and increased Hb toward normal levels
compared to diabetic control rats (Table 2).
Effect of ethanolic extract of CZ and SC on lipid profiles
There was a significant (p< 0.05) increase in total cholesterol
(TC), low density lipoprotein (LDL), very low density lipopro-Z) and Syzygium cumini (SC) in STZ-induced diabetic rats
2 weeks 3 weeks 4 weeks
78.4 ± 4.9 75.9 ± 5.1 81.2 ± 6.2
284.1 ± 17.3a 262.4 ± 15.1a 297.0 ± 2a
139.2 ± 15.2b* 107.7 ± 9.7b* 92.3 ± 8.2b*
147.4 ± 11.4c* 125.3 ± 0.1c* 122.9 ± 11.2c*
Table 2 Effect of Cinnamomum zeylanicum (CZ) and Syzy-
gium cumini (SC) on serum insulin, Hb and HbA1c in STZ-
induced diabetic rats (mean ± SE) (n= 6).
Treatments Serum insulin
(IU/mL)
Hb (g/dL) HbA1c (%)
Normal control 2.73 ± 0.09 14.07 ± 0.49 7.02 ± 0.17
Diabetic control 0.87 ± 0.04a 8.56 ± 0.52a 12.07 ± 0.30a
SC treatment 1.35 ± 0.08b 12.35 ± 0.64b 9.56 ± 0.19b
CZ treatment 0.99 ± 0.06c 10.27 ± 0.37c 10.03 ± 0.13c
Hemoglobin (Hb); glycated hemoglobin (HbA1c).
a p< 0.001 between the normal control and diabetic control.
b p< 0.001 between the diabetic control and SC treatment.
c p< 0.05 between the diabetic control and CZ treatment.
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sitely, high density lipoprotein (HDL)-cholesterol levels
recorded a significant (p< 0.05) decrease in STZ diabetic rats
as compared to control rats (Table 3). CZ and SC administra-
tion showed significant (p< 0.001) reduction in elevated TC,
TG, and LDL when compared to diabetic control rats. Also,
a significantly (p< 0.05) increased level of HDL was observed
in diabetic rats after treatment with CZ and SZ compared to
diabetic control rats (Table 3). However, treatment with both
CZ and SC could not produce any significant change in the
levels of VLDL. Finally, treatment with SC showed more sig-
nificant improvements in the lipid levels compared to CZ trea-
ted diabetic rats (Table 3).Table 4 Effect of Cinnamomum zeylanicum (CZ) and Syzygium c
diabetic rats (mean ± SE) (n= 6).
Treatment SGOT (IU/L) SGPT (IU/L) To
Normal control 102.48 ± 4.8 86.36 ± 3.2 8.5
Diabetic control 167.37 ± 7.3a 139.05 ± 4.1a 5.9
SC treatment 136.35 ± 5.6b 99.74 ± 4.1b 6.7
CZ treatment 143.26 ± 3.7c 107.37 ± 3.2c 7.0
Serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruv
a p< 0.05 between the normal control and diabetic control.
b p< 0.05 between the diabetic control and SC treatment.
c p< 0.05 between the diabetic control and CZ treatment.
Table 3 Hypolipidemic activity of Cinnamomum zeylanicum (CZ)
± SE) (n= 6).
Treatment Serum lipid profile (mg/dL)
TC TG
Normal control 56.31 ± 5.19 104.24 ± 4.93
Diabetic control 91.25 ± 6.21a 158.24 ± 5.75a
SC treatment 62.46 ± 5.32b 109.27 ± 4.11b
CZ treatment 71.39 ± 3.97c 124.32 ± 4.18c
Total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL),
a p< 0.05 between the normal control and diabetic control.
b p< 0.05 between the diabetic control and SC treatment.
c p< 0.05 between the diabetic control and CZ treatment.Effect of ethanolic extract of CZ and SC on liver and kidney
functions
Table 4 represents the efficacy of CZ and SC on SGOT, SGPT,
total protein, creatinine and urea levels in diabetic rats. Themen-
tioned biochemical parameters were significantly (p< 0.001)
altered in STZ-induced diabetic rats compared to normal control
rats. In diabetic rats, administration of CZ significantly
(p< 0.05) lowered the increased levels of SGOT, SGPT, crea-
tinine andurea in diabetic control rats. TheSC treatment showed
significantly (p< 0.001) higher reduction of SGOT, SGPT levels
compared to CZ treated diabetic rats (Table 4).
Effect of ethanolic extract of CZ and SC on antioxidant activity
The antioxidant activity of CZ and SC in the liver was studied
in diabetic rats. After the induction of diabetes by STZ, signif-
icant (p< 0.001) decreased levels of SOD, CAT, GPx, reduced
GSH and increased the levels of TBARS in liver were observed
in comparison to normal control rats (Fig. 1). These altered
antioxidant levels were reversed significantly to near normal
levels after the administration of SC (p< 0.001) and CZ
(p< 0.01) by comparing to diabetic and normal control rats
(Fig. 1).
Discussion
STZ [2-deoxy-2-3(3-methyl-3-nitrosoureido)-D-glucopyra
nose] is commonly used to instigate experimental diabetes inumini (SC) on serum biochemical parameters in STZ-induced
tal protein (g/dL) Creatinine (mg/dL) Urea (g/dL)
2 ± 1.62 0.54 ± 0.31 38.48 ± 2.2
8 ± 1.3 0.78 ± 0.42 128.29 ± 5.3a
1 ± 1.0 0.65 ± 0.34 83.39 ± 2.9b
2 ± 0.9 0.69 ± 0.27 69.24 ± 3.9c
ic transaminase (SGPT).
and Syzygium cumini (SC) in STZ-induced diabetic rats (mean
HDL LDL VLDL
71.04 ± 4.36 38.14 ± 3.27 23.48 ± 3.57
37.48 ± 4.20a 91.58 ± 5.39a 31.28 ± 5.21a
58.32 ± 2.49b 61.26 ± 4.48b 28.25 ± 2.56
61.69 ± 5.04c 55.47 ± 3.94c 29.03 ± 2.47
high density lipoprotein (HDL), very low density lipoprotein (VLDL).
Figure 1 Antioxidant activity of Cinnamomum zeylanicum (CZ) and Syzygium cumini (SC) on liver in STZ-induced diabetic rats (mean
± SE) (n= 6). GSH; reduced glutathione, GPx; glutathione peroxidase, SOD; superoxide dismutase, CAT; catalase, MDA;
malondialdehyde. (*p< 0.05; **p< 0.01, ns = not significant.)
130 K. Sharafeldin, M.R. Rizvianimals (Al-Attar and Zari, 2007). In our study, raised blood
glucose level and decreased insulin level were markedly
observed in STZ-induced diabetic rats. The toxicity of STZ
is due to DNA alkylation of its methyl nitrosourea moiety
mainly at the O6 position of guanosine (Szkudelski, 2001).
The transfer of the methyl group from STZ to the DNAmolecule causes damage which results in fragmentation of
DNA and functional imperfections of the beta cells
(Szkudelski, 2001). Moreover, STZ has potential to act as an
intracellular nitric oxide (NO) donor and generates reactive
oxygen species (ROS). The synergistic action of both NO
and ROS may also contribute to DNA fragmentation and
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and SC ethanolic extracts were administered orally at
200 mg/kg body weight. The oral LD50 of cinnamon bark
oil in rats has been determined as 4.16 g/kg body weight.
For cinnamaldehyde, the oral LD 50 in rats is 2.22 g/kg body
weight (ESCOP, 2003). Evaluation of the safety of the
hydroalcoholic extract (HE) of S. cumini (L.) is done in
rodents. Acute toxicity is evaluated through the determination
of an LD50 in mice and rats (up to 14 days). In mice, the oral
administration of the HE (0.1 at 6 g/kg) causes no death (Silva
et al., 2012). In the present study, the oral dose given (200 mg/
kg body weight) has been used in several studies, even more up
to 600 mg/kg, as safe and sublethal doses (Rekha et al., 2008;
Tanko et al., 2008; Alikatte et al., 2012). Administration of CZ
and SC to diabetic rats significantly reduced blood glucose
level from the first week to the fourth week contrasted with
diabetic control rats. Accompanied to that decline of glucose
level, these plant extracts (particularly SC) increased the insu-
lin level compared to diabetic control rats. Consequently, the
hypoglycemic activity of CZ and SC may be due to their pro-
tective action against STZ-mediated damage to the pancreatic
beta cells or regeneration of damaged beta cell. Sharma et al.
(2012) suggest that SC improved glucose homeostasis occurred
through a mechanism that restored b-cell capacity and insulin
activity. Also, Anandharajan et al. (2006) shows that SC aug-
mented glucose uptake by up-regulating the glucose
transporter-4, PPARc, and phosphatidylinositol 3-kinase in
L6 myotubes. The hypoglycemic activity of SC in diabetic rats
has been indicated as a result of increased hexokinase and
decreased glucose-6 phosphatase enzyme activities in the liver,
leading to increased glycogenesis and decreased glycogenolysis
and gluconeogenesis (Sharma et al., 2008). On the other hand,
CZ prevents the development of insulin resistance, at least in
part by enhancing insulin signaling and possibly via the NO
pathway in skeletal muscle (Qin et al., 2010a). Additionally,
other study affirms that CZ increased glucose uptake and
GLUT4 (glucose transporter) expression in 3T3-L1 adipose
cells. It has been revealed that a water extract of cinnamon
(Cinnulin PF) reduces blood glucose level and soluble cluster
of differentiation 36 (CD36), which is reported as a novel mar-
ker of insulin resistance (Handberg et al., 2006; Qin et al.,
2010b). In other study, reduction of blood glucose by CZ
appears by many mechanisms as reducing intestinal glucose
absorption, stimulating cellular glucose uptake, glycogen syn-
thesis, insulin release, potentiating insulin receptor activity and
inhibiting gluconeogenesis (Ranasinghe et al., 2013). Likewise,
cinnamon bark extracts are found potentially useful for the
control of uptake glucose in diabetic patients through inhibi-
tion of intestinal a-glucosidase and pancreatic a-amylase
(Adisakwattana et al., 2011; Kongstad et al., 2015).
Also, the present results demonstrate the increased level of
HbA1c and decreased Hb level in diabetic rats compared to
normal control rats, which may indicate the occurrence of gly-
cosylation in diabetic rats due to hyperglycemia. HbA1c is the
product of non-enzymatic response between glucose and free
amino groups of Hb (glycosylation) (Mohammadi and Naik,
2008). Administration of CZ and SC to the diabetic rats signif-
icantly reduced HbA1c levels and increased Hb levels com-
pared to diabetic control rats. This indication may due to
improved blood glucose level or glycation process inhibition.
HbA1c is a marker of evaluation of long-term glycemic control
in diabetic patients and predicts risks for the development and/or progression of diabetic complications (Tembhurne and
Sakarkar, 2011). Previous studies have reported that 10%
steady reduction in HbA1c determined a 35% risk reduction
for retinopathy, a 25–44% risk reduction for nephropathy
and a 30% risk reduction for neuropathy (Tembhurne and
Sakarkar, 2010). Also, cinnamon has found to prevent glyca-
tion mediated RBC-IgG cross-links and HbA1c accumulation
in diabetes rats (Muthenna et al., 2014). Also, Sartorius et al.
(2014) have recorded a decrease of fasting glucose levels in
heavily obese and insulin resistant mice by CZ extract supple-
mentation for 6 weeks. The previous model shows a decrease
in liver triglyceride content and an increase in glycogen con-
centration alongside improved insulin sensitivity of the liver
and in SC as well (Sartorius et al., 2014; Bitencourt et al.,
2015). Same results are observed after SC extract administra-
tion (Tripathi and Kohli, 2014).
In STZ-induced diabetic rats, elevated levels of SGPT and
SGOT, urea and creatinine were observed. This behavior sug-
gested the occurrence of liver and kidney damages after the
administration of STZ to the rats. Others have referred these
elevations to STZ mediated liver damages, which may cause
leakage of above enzymes into the blood (Calisti and
Tognetti, 2005). The persistent hyperglycemia, hemodynamic
changes within the kidney tissue and free radical generation
mediated renal dysfunction, which results in elevation of urea
and creatinine levels in blood (Aurell and Bjorck, 1992; Prabhu
et al., 2008; Shokeen et al., 2008). Administration of CZ and
SC to the diabetic rats essentially reduced the SGOT, SGPT,
creatinine and urea levels, which indicated the preservative
action of CZ and SC on liver and kidney damages in diabetic
condition. CZ ameliorates diabetes mediated renal malfunc-
tion in rats as evidenced by reduced urinary albumin and cre-
atinine (Muthenna et al., 2014). Ethanolic extract of SC fruit
causes a reduction in serum ALT and AST levels in male
albino rats (Bilal et al., 2011). Also, other study reveals the uti-
lization of CZ as a medicinal plant for kidney and liver dis-
eases (Saganuwan, 2010).
In the diabetic condition, increased levels of TC, TG and
reduced level of HDL along with the altered composition of
LDL particles have been commonly reported (Howard et al.,
2000). The previous study is compatible with our study after
administration of STZ which altered the normal lipid profiles.
TC, TG, LDL and VLDL levels were increased whereas
decreased HDL level was shown when compared to normal
control rats. The same findings have been shown in high-fat
diet diabetic rats by Sharma et al. (2012). These lipid profiles
were turned around to close normal levels after the treatment
with both CZ and SC. This lipid lowering action may be due to
proper stabilization of glucose level and increase in insulin
level after the administration of CZ and SC, which may nor-
malize the disturbed lipid metabolism in diabetic rats. SC
and CZ may inhibit HMG-CoA reductase (3-hydroxy-3-
methyl-glutaryl-CoA reductase) which indicates the decline
of TC level (Sartorius et al., 2014). Therefore, the hypolipi-
demic effect of CZ and SC in diabetic rats supports their abil-
ity to prevent the cardiovascular diseases associated with
diabetes. The decrease of liver triglyceride content which
accompanied with increased glycogen storage by CZ adminis-
tration has been noticed (Sartorius et al., 2014).
Hyperglycemia increases the generation of free radicals by
glucose auto-oxidation and the increment in free radicals
thereby depleting the activity of antioxidant defense system
132 K. Sharafeldin, M.R. Rizviand thus promoting de novo free radical generation that may
lead to liver cell damage (Baynes and Thorpe, 1999). That
explanation is noticed currently by the elevated GOT and
GPT enzymes in STZ treated rats. Endogenous enzymatic
antioxidants CAT, SOD and GSH act as reducing agents
and detoxified highly reactive oxygen and nitrogen species.
The measured GSH, GPx, CAT and SOD are markedly
depressed. A marked increase of LPO as TBARS in STZ trea-
ted rats was also observed. That increase may lead to tissue
injury and failure of the endogenous antioxidant defense mech-
anisms to prevent over production of free radicals (Maritim
et al., 2003). LPO, GSH, GPx, CAT and SOD levels were
restored toward normal level in CZ and SC treated diabetic
rats in a dose-dependent manner. Same result of SC has been
found by Sharma et al. (2012). This antioxidative effect has
been done by polyphenols present in SC pulp, which acts as
strong singlet oxygen quenchers and superoxide radical
(Banerjee et al., 2005). Increased level of SOD by CZ and
SC helps to convert superoxide free radicals to hydrogen per-
oxide which is then decomposed by increased CAT level. GPx
and GSH complete the decomposition process of extra hydro-
gen peroxide produced. Hyperglycemia is an essential reason
for the release of free radicals, which develop the diabetic com-
plications including vascular disease, retinopathy and renopa-
thy (Maritim et al., 2003). Currently, antioxidants are
suggested as mechanism underlying diabetes and its complica-
tions. Food of plant origin as SC is reported to contain antho-
cyanins cyanidin, tannins, vitamin C, gallic acid, glucoside,
malvidin, and petunidin which have the antioxidative potency
(van Acker et al., 1996; Rupasinghe et al., 2003; Sroka and
Cisowski, 2003). The phenolic constituents of CZ are likely
to be responsible for the anti-oxidant and free radical scaveng-
ing activity (Ranasinghe et al., 2012; Im et al., 2014).
In conclusion, the present study indicates that treatment
with C. zeylanicum and S. cumini had an ideal impact not only
as anti-hyperglycemia but also on lipidic profile, liver and kid-
ney function improvement and as a powerful antioxidant.
These findings point out the promising effect of C. zeylanicum
and S. cumini as helpful antidiabetic specialists, preventing any
diabetic entanglements, the therapeutic efficacy of which can
be only conceivable after clinical trial.Conﬂict of interest statement
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